Response evaluation criteria in solid tumors

Results: 74



#Item
11Ovarian cancer / Chemotherapy / Radiation therapy / Metastasis / Prostate cancer / Response Evaluation Criteria in Solid Tumors / Medicine / Oncology / Gynaecological cancer

A phase 1 study of phospholipid etherI]-CLR1404 in patients with advanced solid

Add to Reading List

Source URL: cellectar.com

Language: English - Date: 2014-07-17 12:12:17
12Medical physics / Medical imaging / Clinical research / Pharmaceutical industry / Clinical trial / Magnetic resonance imaging / Radiology / Invoice / Response Evaluation Criteria in Solid Tumors / Medicine / Health / Epidemiology

Date: Date Received by Radiology: Copy of Study Protocol submitted to Radiology? YES NO Protocol Number:

Add to Reading List

Source URL: www.austin.org.au

Language: English - Date: 2014-09-23 22:34:56
13Alkylating antineoplastic agents / X-ray computed tomography / Response Evaluation Criteria in Solid Tumors / Carboplatin / Lung cancer / Gemcitabine / Chemistry / Medicine / Bevacizumab

Calibration of computed tomography (CT) volumetric measurements for assessing tumour response to drug therapy in a randomised multicentre oncology study Ricardo Avila,1 David Yankelevitz,2 Venice Archer,3 Gudrun Zahlmann

Add to Reading List

Source URL: preventcancer.org

Language: English - Date: 2013-06-24 16:44:47
14Research / Clinical research / Clinical trials / Epidemiology / End point of clinical trials / Clinical endpoint / Response Evaluation Criteria in Solid Tumors / TroVax / Bevacizumab / Medicine / Medical statistics / Health

Understanding Clinical Trials HR = 0.60 (CI : 0.51–0.70) p<0.0001

Add to Reading List

Source URL: www.roche.com

Language: English - Date: 2015-01-10 07:27:14
15Research / Clinical research / Clinical trials / Epidemiology / End point of clinical trials / Clinical endpoint / Response Evaluation Criteria in Solid Tumors / TroVax / Bevacizumab / Medicine / Medical statistics / Health

Understanding Clinical Trials HR = 0.60 (CI : 0.51–0.70) p<0.0001

Add to Reading List

Source URL: www.roche.com

Language: English - Date: 2014-05-27 02:22:43
16Cancer research / Response Evaluation Criteria in Solid Tumors

PHASE II STUDY OF ORAL ENMD-2076 ADMINISTERED TO PATIENTS WITH OVARIAN CLEAR CELL CARCINOMA: A TRIAL OF THE PRINCESS MARGARET PHASE II CONSORTIUM (NCT01914510) Cristina Martin-Lorente1, David SP Tan1, Neesha Dhani1, Marc

Add to Reading List

Source URL: www.casipharmaceuticals.com

Language: English - Date: 2014-06-04 12:59:36
17Science / Food and Drug Administration / SDTM / Clinical Data Interchange Standards Consortium / Data analysis / End point of clinical trials / Response Evaluation Criteria in Solid Tumors / Oncology / Progression-free survival / Clinical trials / Medicine / Research

PharmaSUG China Design and Construct Efficacy Analysis Datasets in Late Phase Oncology Studies Huadan Li, MSD R&D (China) Co., Ltd., Beijing, China Changhong Shi, MSD R&D (China) Co., Ltd., Beijing, China

Add to Reading List

Source URL: www.pharmasug.org

Language: English - Date: 2014-09-01 22:22:42
18Research / Statistics / Response Evaluation Criteria in Solid Tumors / Clinical Data Interchange Standards Consortium / Oncology / Medicine / Food and Drug Administration / SDTM

rd PharmaSUG China 3 Conference, 2014 Brief Introduction of Oncology Domains in SDTMIG, Version 3.2

Add to Reading List

Source URL: www.pharmasug.org

Language: English - Date: 2014-09-01 22:22:38
19Neuroendocrine tumor / Magnetic resonance imaging / Liver cancer / Response Evaluation Criteria in Solid Tumors / Medicine / Hepatology / Hepatocellular carcinoma

MRI Appearance of Focal Liver Lesions with Gadofosveset Trisodium Investigator: Dr. Laurent Milot, Associate Professor, Department of Medical Imaging, University of Toronto, ON, Canada Objectives Focal liver lesions (FLL

Add to Reading List

Source URL: www.car.ca

Language: English - Date: 2013-10-04 09:38:39
20Eastern Cooperative Oncology Group / National Cancer Institute / Response Evaluation Criteria in Solid Tumors / The Cancer Genome Atlas / Cancer and Leukemia Group B / Medicine / Cancer organizations / Cancer research

Molecular Analysis for Therapy Choice (NCI-MATCH) A Joint National Cancer Institute (NCI) and National Clinical Trials Network (NCTN) Clinical Trial September 2014

Add to Reading List

Source URL: dctd.cancer.gov

Language: English - Date: 2014-09-18 12:23:02
UPDATE